Muller Y A, Christinger H W, Keyt B A, de Vos A M
Department of Protein Engineering, Genentech, Inc., South San Francisco, CA 94080, USA.
Structure. 1997 Oct 15;5(10):1325-38. doi: 10.1016/s0969-2126(97)00284-0.
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific angiogenic and vasculogenic mitogen. VEGF also plays a role in pathogenic vascularization which is associated with a number of clinical disorders, including cancer and rheumatoid arthritis. The development of VEGF antagonists, which prevent the interaction of VEGF with its receptor, may be important for the treatment of such disorders. VEGF is a homodimeric member of the cystine knot growth factor superfamily, showing greatest similarity to platelet-derived growth factor (PDGF). VEGF binds to two different tyrosine kinase receptors, kinase domain receptor (KDR) and Fms-like tyrosine kinase 1 (Flt-1), and a number of VEGF homologs are known with distinct patterns of specificity for these same receptors. The structure of VEGF will help define the location of the receptor-binding site, and shed light on the differences in specificity and cross-reactivity among the VEGF homologs.
We have determined the crystal structure of the receptor-binding domain of VEGF at 1.93 A resolution in a triclinic space group containing eight monomers in the asymmetric unit. Superposition of the eight copies of VEGF shows that the beta-sheet core regions of the monomers are very similar, with slightly greater differences in most loop regions. For one loop, the different copies represent different snapshots of a concerted motion. Mutagenesis mapping shows that this loop is part of the receptor-binding site of VEGF.
A comparison of the eight independent copies of VEGF in the asymmetric unit indicates the conformational space sampled by the protein in solution; the root mean square differences observed are similar to those seen in ensembles of the highest precision NMR structures. Mapping the receptor-binding determinants on a multiple sequence alignment of VEGF homologs, suggests the differences in specificity towards KDR and Flt-1 may derive from both sequence variation and changes in the flexibility of binding loops. The structure can also be used to predict possible receptor-binding determinants for related cystine knot growth factors, such as PDGF.
血管内皮生长因子(VEGF)是一种内皮细胞特异性的血管生成和血管发生有丝分裂原。VEGF在与多种临床疾病相关的病理性血管生成中也起作用,这些疾病包括癌症和类风湿性关节炎。开发可阻止VEGF与其受体相互作用的VEGF拮抗剂,可能对治疗此类疾病具有重要意义。VEGF是胱氨酸结生长因子超家族的同型二聚体成员,与血小板衍生生长因子(PDGF)最为相似。VEGF与两种不同的酪氨酸激酶受体,即激酶结构域受体(KDR)和Fms样酪氨酸激酶1(Flt-1)结合,并且已知许多VEGF同源物对这些相同受体具有不同的特异性模式。VEGF的结构将有助于确定受体结合位点的位置,并阐明VEGF同源物之间特异性和交叉反应性的差异。
我们已经在三斜晶系空间群中以1.93埃的分辨率确定了VEGF受体结合结构域的晶体结构,该空间群的不对称单元中包含八个单体。VEGF的八个拷贝的叠加显示,单体的β-折叠核心区域非常相似,大多数环区域的差异稍大。对于一个环,不同的拷贝代表协同运动的不同瞬间。诱变图谱显示该环是VEGF受体结合位点的一部分。
对不对称单元中VEGF的八个独立拷贝进行比较,表明蛋白质在溶液中采样的构象空间;观察到的均方根差异与最高精度NMR结构集合中看到的相似。在VEGF同源物的多序列比对上绘制受体结合决定簇,表明对KDR和Flt-1的特异性差异可能源于序列变异和结合环灵活性的变化。该结构还可用于预测相关胱氨酸结生长因子(如PDGF)可能的受体结合决定簇。